Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Schrodinger Inc (NQ: SDGR ) 17.16 -0.35 (-2.00%) Streaming Delayed Price Updated: 11:44 AM EDT, Oct 7, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Schrodinger Inc < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > 3 AI Stocks to Buy for the Future of Automation February 17, 2023 Increased appreciation for AI and the Street's reduced hostility to growth stocks make this a good time to find AI stocks to buy. Via InvestorPlace Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 17, 2023 From Schrödinger, Inc. Via Business Wire Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda February 14, 2023 From Schrödinger Inc. Via Business Wire Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know January 31, 2023 Via Benzinga 4 Analysts Have This to Say About Schrodinger January 31, 2023 Via Benzinga Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28 February 13, 2023 From Schrödinger Via Business Wire Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development February 04, 2023 Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a... Via Talk Markets Schrödinger to Present at SVB Securities Global Biopharma Conference January 31, 2023 From Schrödinger Via Business Wire Week In Review: Mabwell Out-Licenses Rare Disease Drug For $412.5 Million January 21, 2023 Mabwell Biosciences out-licensed global rights for a rare disease drug to Disc Medicine of Cambridge, MA in a $412.5 million agreement. Mabwell will receive $10 million upfront, $402.5 million in... Via Talk Markets Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) January 20, 2023 From Schrödinger Via Business Wire Schrödinger Provides Update on Progress Across the Business and Outlines 2023 Company Strategic Priorities January 09, 2023 From Schrödinger, Inc. Via Business Wire Why These 7 Healthcare Stocks Could Soar in 2023 January 02, 2023 These healthcare stocks to buy are trading at a hefty discount and are poised to deliver robust returns in 2023. Via InvestorPlace 7 Drug Stocks That Will Soar in 2023 December 22, 2022 These drug stocks to buy look poised to generate huge profits for investors in 2023 and in subsequent years. Via InvestorPlace Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) December 16, 2022 From Schrödinger, Inc. Via Business Wire Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session December 13, 2022 Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial. Via Benzinga Schrödinger Presents New Preclinical Data Supporting Advancement of CDC7 Inhibitor Development Candidate, SGR-2921, at American Society of Hematology 2022 Annual Meeting December 12, 2022 From Schrödinger Via Business Wire Stocks That Hit 52-Week Lows On Monday December 05, 2022 During Monday's session, 49 companies made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday December 02, 2022 On Friday, 72 companies hit new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session November 28, 2022 Via Benzinga Schrödinger to Present at Piper Sandler 34th Annual Healthcare Conference November 21, 2022 From Schrödinger Via Business Wire Stocks That Hit 52-Week Lows On Monday November 28, 2022 On Monday, 79 companies reached new 52-week lows. Via Benzinga Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) November 18, 2022 From Schrödinger Via Business Wire Schrödinger to Present at Jefferies 13th Annual London Healthcare Conference November 07, 2022 From Schrödinger Via Business Wire Yelp, Twilio, Atlassian, And Other Big Losers From Friday November 07, 2022 U.S. stocks closed higher on Friday, with the Dow Jones surging more than 400 points. Here is the list of some big stocks recording losses in the previous session. Via Benzinga 3 Hypergrowth Stocks That Will Make You a Millionaire by 2027 November 04, 2022 These companies' great third-quarter results, along with their very promising technologies, are likely to turn them into hypergrowth stocks. Via InvestorPlace Schrödinger Reports Third Quarter 2022 Financial Results November 03, 2022 From Schrödinger, Inc. Via Business Wire Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday November 07, 2022 Gainers Via Benzinga Stocks That Hit 52-Week Lows On Friday November 04, 2022 Friday's session saw 236 companies set new 52-week lows. Via Benzinga Schrödinger To Present New Preclinical Data From Its CDC7 Inhibitor Program At American Society Of Hematology 2022 Annual Meeting November 03, 2022 From Schrödinger, Inc. Via Business Wire Earnings Scheduled For November 3, 2022 November 03, 2022 Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion. Via Benzinga < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.